Clinical Trial Update: ELND005 Long-Term Follow-up Study in Subjects With Alzheimer's Disease [Phase 2]

View source ↗

Summary

Phase 2 long-term follow-up study in Alzheimer's disease completed; results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• ELND005

Snippet

Sponsor: OPKO Health, Inc. | Conditions: Alzheimer's Disease | Phase 2 | Status: COMPLETED | Results posted: 2015-05-13